Durable complete remission of therapy-refractory, tumor-stage cutaneous T-cell lymphoma under radioimmunotherapy with electron beam irradiation and denileukin diftitox

Arch Dermatol. 2010 Jul;146(7):805-6. doi: 10.1001/archdermatol.2010.147.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Diphtheria Toxin / administration & dosage
  • Diphtheria Toxin / therapeutic use*
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Foot
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Lymphoma, T-Cell, Cutaneous / diagnosis
  • Lymphoma, T-Cell, Cutaneous / therapy*
  • Male
  • Neoplasm Staging
  • Radiotherapy, Adjuvant
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / therapeutic use
  • Remission Induction / methods*
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Diphtheria Toxin
  • Interleukin-2
  • Recombinant Fusion Proteins
  • denileukin diftitox